Klein, Alison P.

Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance

Abe, T., Blackford, A. L., Tamura, K., Ford, M., McCormick, P., Chuidian, M., Almario, J. A., Borges, M., Lennon, A. M., Shin, E. J., et al. (2019) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchBRCA gene mutations in cancer

Cited by 102

Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene

Hsu, F.-C., Roberts, N. J., Childs, E., Porter, N., Rabe, K. G., Borgida, A., Ukaegbu, C., Goggins, M. G., Hruban, R. H., Zogopoulos, G., et al. (2021) · JAMA Oncology

Pancreatic and Hepatic Oncology ResearchBRCA gene mutations in cancer

Cited by 91

The Role of Inherited Pathogenic CDKN2A Variants in Susceptibility to Pancreatic Cancer

Kimura, H., Klein, A. P., Hruban, R. H., & Roberts, N. J. (2021) · Pancreas

Pancreatic and Hepatic Oncology ResearchBRCA gene mutations in cancer

Cited by 65

Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance

Kimura, H., Paranal, R. M., Nanda, N., Wood, L. D., Eshleman, J. R., Hruban, R. H., Goggins, M. G., Klein, A. P., The Familial Pancreatic Cancer Genome Sequencing Project, & Roberts, N. J. (2022) · eLife

Pancreatic and Hepatic Oncology ResearchGenomics and Rare Diseases

Cited by 23